Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.

Sacks, Chana A; Lee, ChangWon C; Kesselheim, Aaron S; Avorn, Jerry

Sacks, Chana A; Lee, ChangWon C; Kesselheim, Aaron S; Avorn, Jerry.

Afiliación

Sacks CA; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Lee CC; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Kesselheim AS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Avorn J; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

JAMA ; 320(7): 650-656, 2018 08 21.

Article en En | MEDLINE | ID: mdl-30140875

Asunto(s)

Costos de los Medicamentos; Medicamentos Genéricos/economía; Gastos en Salud/estadística & datos numéricos; Medicare Part D/economía; Medicamentos bajo Prescripción/economía; Estudios Retrospectivos; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Medicamentos Genéricos / Costos de los Medicamentos / Gastos en Salud / Medicare Part D / Medicamentos bajo Prescripción Tipo de estudio: Observational_studies País/Región como asunto: America do norte Idioma: En Revista: JAMA Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google